Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Non-Current Debt (2020 - 2024)

Bio Essence has reported Non-Current Debt over the past 5 years, most recently at $1.4 million for Q1 2024.

  • Quarterly results put Non-Current Debt at $1.4 million for Q1 2024, up 6064.53% from a year ago — trailing twelve months through Mar 2024 was $1.4 million (up 6064.53% YoY), and the annual figure for FY2023 was $608631.0, up 2281.09%.
  • Non-Current Debt for Q1 2024 was $1.4 million at Bio Essence, up from $608631.0 in the prior quarter.
  • Over the last five years, Non-Current Debt for BIOE hit a ceiling of $1.4 million in Q1 2024 and a floor of $14549.0 in Q2 2021.
  • Median Non-Current Debt over the past 5 years was $33443.0 (2022), compared with a mean of $191109.6.
  • Biggest five-year swings in Non-Current Debt: crashed 83.48% in 2022 and later surged 6064.53% in 2024.
  • Bio Essence's Non-Current Debt stood at $212750.0 in 2020, then crashed by 82.18% to $37918.0 in 2021, then crashed by 32.59% to $25561.0 in 2022, then skyrocketed by 2281.09% to $608631.0 in 2023, then soared by 125.22% to $1.4 million in 2024.
  • The last three reported values for Non-Current Debt were $1.4 million (Q1 2024), $608631.0 (Q4 2023), and $17288.0 (Q3 2023) per Business Quant data.